Takeda Pharmaceuticals (formerly Nycomed) Email Format
Pharmaceutical ManufacturingZurich, Switzerland501-1000 Employees
Nycomed US Inc. is a global pharmaceutical manufacturer with a diversified portfolio spanning branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis, and tissue management, complemented by over-the-counter products. Its research and development relies on collaborations, with in-licensing and expansion in emerging markets identified as key growth drivers. The company is headquartered in the Zurich region, with a presence in Opfikon, and in 2011 it was acquired by Takeda Pharmaceutical Company Limited, expanding Takeda's global reach. Nycomed's products have been marketed in more than 100 countries, supported by strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia, and the Middle East. In the United States and Japan, products were available through partner networks. This overview reflects Nycomed as it existed prior to the Takeda acquisition.